*  Topical Administration of Manuka Oil Prevents UV-B Irradiation-Induced Cutaneous Photoaging in Mice
... Oh Sook Kwon,1 Seung Hee ... S. R. Pinnell, "Cutaneous photodamage, oxidative stress, and topical antioxidant protection," Journal of the American Academy ... β-carotene in cutaneous photoprotection," Free Radical Biology and Medicine, vol. 25, no. 7, pp. 848-873, 1998. View at ...
  https://www.hindawi.com/journals/ecam/2013/930857/ref/
*  Effective Administration of Rituximab in Anti-MDA5 Antibody-Positive Dermatomyositis with Rapidly Progressive Interstitial Lung...
... his respiratory insufficiency and cutaneous involvement progressively worsened. However, the administration of rituximab (RTX) ... Effective Administration of Rituximab in Anti-MDA5 Antibody-Positive Dermatomyositis with Rapidly Progressive Interstitial Lung ... and refractory cutaneous involvement together with high levels of anti-melanoma differentiation-associated gene 5 antibody ( ... Disease and Refractory Cutaneous Involvement: A Case Report and Literature Review. Yuka Ogawa,1 Dai Kishida,1 Yasuhiro ...
  https://www.hindawi.com/journals/crirh/2017/5386797/abs/
*  Patent US20080306436 - Devices, Systems, and Methods for Medicament Delivery - Google Patents
Cutaneous administration system. US6726661 *. Dec 10, 2002. Apr 27, 2004. Novo Nordisk A/S. Air shot mechanism for electronic ... Device for the administration of drugs, particularly two-component drugs. US5383851 *. Jul 24, 1992. Jan 24, 1995. Bioject Inc. ... Administration instrument for medical use. US20060030819 *. Apr 1, 2005. Feb 9, 2006. Meridian Medical Technologies Inc.. ... Smart parenteral administration system. US9089636. Jul 5, 2005. Jul 28, 2015. Valeritas, Inc.. Methods and devices for ...
  http://www.google.com/patents/US20080306436?dq=3691140
*  Patent US5511726 - Nebulizer device - Google Patents
Cutaneous administration system. US6796303 *. 3 Jun 2002. 28 Sep 2004. Battelle Pulmonary Therapeutics, Inc.. Pulmonary aerosol ... Cutaneous administration system. US20040184999 *. 29 Jan 2004. 23 Sep 2004. Alexza Molecular Delivery Corporation. Delivery of ... Cutaneous administration system. US7550133. 20 Nov 2003. 23 Jun 2009. Alexza Pharmaceuticals, Inc.. Respiratory drug ...
  http://www.google.ca/patents/US5511726
*  A Smoking Cessation Trial in HIV-infected Patients in South Africa - Full Text View - ClinicalTrials.gov
administration, cutaneous. Additional relevant MeSH terms: Nicotine. Ganglionic Stimulants. Autonomic Agents. Peripheral ...
  https://clinicaltrials.gov/ct2/show/study/NCT01484340?view=results
*  Novel approach to improve permeation of ondansetron across shed snake skin as a model membrane.
Administration, Cutaneous. Animals. Ethanol / pharmacology. Humans. Models, Animal. Molting*. Oleic Acid / pharmacology. ...
  http://www.biomedsearch.com/nih/Novel-approach-to-improve-permeation/11428654.html
*  Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive...
Administration, Cutaneous. Analysis of Variance. Blotting, Western. Case-Control Studies. Dose-Response Relationship, Drug. ... cutaneous vascular conductance; P,0.05) and neuronal NO synthase-inhibited sites (94±4% versus 77±3% cutaneous vascular ... iNOS inhibition augmented the NO-dependent local heating response (93±2% versus 89±10% cutaneous vascular conductance). ... Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive ...
  http://www.biomedsearch.com/nih/Upregulation-Inducible-Nitric-Oxide-Synthase/21931069.html
*  Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics,...
Administration, Cutaneous. Administration, Inhalation. Adolescent. Child. Cross-Over Studies. Dose-Response Relationship, Drug ... Human Growth Hormone / administration & dosage*, adverse effects*, deficiency, pharmacokinetics*. Humans. Male. Patient ...
  http://www.biomedsearch.com/nih/Inhaled-Growth-Hormone-GH-Compared/19336514.html
*  Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy |...
Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy. ... Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy ... Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy ... Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy ...
  http://cancerimmunolres.aacrjournals.org/content/early/2013/10/22/2326-6066.CIR-13-0092
*  EPO - T 1164/11 () of 18.2.2015
Medical apparatus for cutaneous administration of mendicaments. Applicant name:. C.I.R.C.E S.R.L.. ... which gave the energy to penetrate the cutaneous barrier and deliver the active principle to the target area, was rubbed on the ...
  http://www.epo.org/law-practice/case-law-appeals/recent/t111164eu1.html
*  Idrocilamide - Wikipedia
Tissue and systemic diffusion of idrocilamide after cutaneous administration]". Revue du Rhumatisme (in French). 60 (12): 932-6 ...
  https://en.wikipedia.org/wiki/Idrocilamide
*  Die ältere Patientin mit Wallungen | SpringerLink
Menopause Conjugated equine estrogens Administration, cutaneous Venous thromboembolism Stroke Mortality Cardiovascular risk ... Renoux C, Suissa S (2011) Hormone Therapy administration in postmenopausal women and risk of stroke. Women's Health 7(3):355- ...
  https://link.springer.com/article/10.1007/s10304-018-0184-0
*  The ternary phase diagram under different proportion co | Open-i
Administration, Cutaneous. *Animals. *Castor Oil/analogs & derivatives/chemistry. *Drug Stability. *Female. *Mice ...
  https://openi.nlm.nih.gov/detailedresult.php?img=PMC3107722_ijn-6-649f3&req=4
*  Comparison of insulin release profiles obtained with th | Open-i
Comparison of insulin release profiles obtained with the Franz diffusion cell.(a) Comparison of cumulative insulin release profiles of the DMN patch compared wi
  https://openi.nlm.nih.gov/detailedresult.php?img=PMC4300505_srep07914-f4&req=4
*  Hyperactivation of P21ras and the Hematopoietic-Specific Rho Gtpase, Rac2, Cooperate to Alter the Proliferation of...
Mice in Response to Local Cutaneous Administration of SCF Is Mediated through Rac2 In Vivo.. Local cutaneous injection of SCF ... C) Number of cutaneous mast cells per mm2 in Nf1+/− and wild-type mice in response to local administration of various ... Effect of heterozygosity of Nf1 on accumulation of cutaneous mast cells in response to local administration of SCF in vivo. (A ... Representative skin biopsy stained for cutaneous mast cells taken from the site of SCF administration via a microosmotic pump ...
  http://jem.rupress.org/content/194/1/57
*  Photograph of(A) a single microneedle coated with influ | Open-i
Administration, Cutaneous*. *Influenza A Virus, H3N2 Subtype/immunology*. *Influenza Vaccines/administration & dosage* ... In view of the convenience of delivery and the potential for self-administration, vaccine-coated metal microneedles may provide ... In view of the convenience of delivery and the potential for self-administration, vaccine-coated metal microneedles may provide ... and induction of virus-specific memory B-cells.In view of the convenience of delivery and the potential for self-administration ...
  https://openi.nlm.nih.gov/detailedresult.php?img=PMC2651574_pone.0004773.g001&req=4
*  angiokeratoma in tub sclerosis 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
MeSH-minor] Administration, Cutaneous. Animals. Cell Line, Tumor. Disease Models, Animal. Mice. Mice, Nude. Neoplasm ... Sirolimus / administration & dosage. Tuberous Sclerosis / complications. *[MeSH-minor] Administration, Topical. Adolescent. ... Enzyme Inhibitors / administration & dosage. Protein Kinases / drug effects. Sirolimus / administration & dosage. Soft Tissue ... Sun XF, Yan CL, Fang L, Shen FM, Liao KH: Cutaneous lesions and visceral involvement of tuberous sclerosis. Chin Med J (Engl); ...
  http://www.bmlsearch.com/?kwr=angiokeratoma+in+tub+sclerosis+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
*  Publications | Département de chimie
Biocompatible polymer-metal-organic framework composite patches for cutaneous administration of cosmetic molecules. J. Mater. ...
  http://www.chimie.ens.fr/?q=biblio/author/3833
*  Patent US7230088 - Compounds for dual photodiagnosis and therapy - Google Patents
... or cutaneous administration. Topical or cutaneous delivery of the photosensitizer may also include aerosol formulation, creams ... Formulations for enteral administration may vary widely, as is well known in the art. In general, such formulations are liquids ... After administration, the composition accumulates, for example, at a target tissue if a targeting moiety is included in the ... After administration, the composition accumulates, for example, at a target tissue if a targeting moiety is included in the ...
  http://www.google.com/patents/US7230088?dq=patent:5881444
*  recurrent hepatoma drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
MeSH-minor] Administration, Cutaneous. Aged. Female. Hepatitis C / complications. Humans. Injections, Intralesional / methods. ... Cisplatin / administration & dosage. Drug Administration Schedule. Female. Fluorouracil / administration & dosage. Hepatic ... Cefmetazole / administration & dosage. Cilastatin / administration & dosage. Cisplatin / administration & dosage. Female. Fever ... MeSH-minor] Administration, Oral. Biomarkers, Tumor / blood. Drug Administration Schedule. Humans. Male. Middle Aged. Protein ...
  http://www.bmlsearch.com/?kwr=recurrent+hepatoma+drug+therapy+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1
*  Nystatin - Wikipedia
On occasion, serum levels of the drug can be identified from oral, vaginal, or cutaneous administration, and lead to toxicity. ...
  https://en.wikipedia.org/wiki/Nystatin
*  Sex Steroids and Lipoproteins | SpringerLink
Fahraeus L, Wallentin L. High density lipoprotein subtraction during oral and cutaneous administration of 17 beta-estradiol to ... Fahraeus L, Larsson-Cohn U, Wallentin L. Lipoproteins during oral and cutaneous administration of estradiol-17 beta to ... Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol. Am J Obstet Gynecol 1985;151:868-877. ... The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab 1983; ...
  https://link.springer.com/chapter/10.1007/978-1-4612-3014-4_5